ArticleJAMA neurology2015

Neurogranin as a Cerebrospinal Fluid Biomarker for Synaptic Loss in Symptomatic Alzheimer Disease.

Maartje I Kester et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.